Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948058 · ClinicalTrials.gov registry record · NA
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
A NA study of Smoking Cessation and Obesity and Obesity-related Medical Conditions, sponsored by Brown University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06948058: Recruiting NA study of Smoking Cessation and Obesity and Obesity-related Medical Conditions, sponsored by Brown University.
NCT06948058 is a NA study of Smoking Cessation and Obesity and Obesity-related Medical Conditions that is actively recruiting participants, run by Brown University. The registered enrollment target is 60 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06948058, a NA study of Smoking Cessation and Obesity and Obesity-related Medical Conditions, is actively recruiting participants, sponsored by Brown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will investigate the effects of alternative nicotine products on smoking, weight gain, and related outcomes.
Primary Outcome
Daily use of cigarettes will be determined using the Timeline Follow-Back (TLFB) in follow-up assessments.
Conditions Studied
Interventions
- OTHER Electronic Cigarettes (EC)
- OTHER Nicotine replacement therapy (NRT)
Study Locations (1)
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT06948058 shows while recruiting
NCT06948058 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Electronic Cigarettes (EC) is the first listed.
NCT06948058 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06948058 about?
NCT06948058 is a clinical study titled "Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy". This project will investigate the effects of alternative nicotine products on smoking, weight gain, and related outcomes.
What is the current status of trial NCT06948058?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-01. Estimated completion is 2027-08-31.
What conditions does trial NCT06948058 study?
This clinical trial studies the following conditions: Smoking Cessation, Obesity and Obesity-related Medical Conditions.
What interventions are being tested in trial NCT06948058?
The interventions under investigation include: Electronic Cigarettes (EC) (OTHER), Nicotine replacement therapy (NRT) (OTHER).
Who is sponsoring clinical trial NCT06948058?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06948058 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06948058's enrollment target sits among peer trials
60 137th of 188 higher than 51 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
-
Remote Smoking Cessation in Hospitalized Cardiac Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI